SLA going to have to be something out of the Box to have a market cap of approx $160 mill and keep the uptrend intact with no hiccups along the way.
It is a long way away from ever becoming profitable imho and yet there are other biotech companys out there that have revenues in the 10's of millions per year, are profitable and yet their market caps are a fraction of SLA's.
It is running on unsustainable sentiment i think.